Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Redox-stable, Non-Phosphorylated Cyclic Peptide Inhibitors of SH2 Domain binding to Target Protein, Conjugates Thereof, Compositions...

  • Read more about Redox-stable, Non-Phosphorylated Cyclic Peptide Inhibitors of SH2 Domain binding to Target Protein, Conjugates Thereof, Compositions...
US Application 60/137,187
Filed on 1999-06-02

Method For Production Of Layered Expression Scans For Tissue And Cell Samples

  • Read more about Method For Production Of Layered Expression Scans For Tissue And Cell Samples
US Application 60/145,613
Filed on 1999-07-26

Agents That Bind to and Inhibit Human Cytochrome P450 2C8, 2C9, 2C18, and 2C19

  • Read more about Agents That Bind to and Inhibit Human Cytochrome P450 2C8, 2C9, 2C18, and 2C19
US Application 60/119,972
Filed on 1999-02-12

Acetylated and Related Analogues of Chicoric Acid as HIV-1 Integrase Inhibitors

  • Read more about Acetylated and Related Analogues of Chicoric Acid as HIV-1 Integrase Inhibitors
US Application 60/121,127
Filed on 1999-02-22

Transition Metal Complexes of N ,N',N-Trialkyl-CIS,CIS-1,3,5- Triaminocyclohexane & Related Compositions & Methods of Synthesis...

  • Read more about Transition Metal Complexes of N ,N',N-Trialkyl-CIS,CIS-1,3,5- Triaminocyclohexane & Related Compositions & Methods of Synthesis...
US Application 60/148,051
Filed on 1999-08-10

Ac-HEHA and Related Compounds, Methods of Synthesis and Methods of Use

  • Read more about Ac-HEHA and Related Compounds, Methods of Synthesis and Methods of Use
US Application 60/125,764
Filed on 1999-03-23

Method of Predicting Susceptibility to HIV Infection or Progression of HIV Disease

  • Read more about Method of Predicting Susceptibility to HIV Infection or Progression of HIV Disease
US Application 60/128,521
Filed on 1999-04-09

Methods of Inhibiting the HGF-Met-uPA-Plasmin Network

  • Read more about Methods of Inhibiting the HGF-Met-uPA-Plasmin Network
US Application 60/119,114
Filed on 1999-02-08

POLYPEPTIDES COMPRISING IL-6 LIGAND-BINDING RECEPTOR DOMAINS AND RE- LATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS AND METHODS OF USE

  • Read more about POLYPEPTIDES COMPRISING IL-6 LIGAND-BINDING RECEPTOR DOMAINS AND RE- LATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS AND METHODS OF USE
US Application 60/151,277
Filed on 1999-08-27

Hydrazide Inhibitors of HIV-1 Integrase

  • Read more about Hydrazide Inhibitors of HIV-1 Integrase
US Application 60/124,302
Filed on 1999-03-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health